missing translation for 'onlineSavingsMsg'
Learn More

Tocris Bioscience™ ML 162

Inhibits glutathione peroxidase (GPX4); induces ferroptosis

188.00€ - 737.00€

Specifications

Chemical Name or Material 2-[(Chloroacetyl)(3-chloro-4-methoxyphenyl)amino]-N-(2-phenylethyl)-2-thien-2-ylacetamide
CAS 1035072-16-2
Target Glutathione Peroxidase 4/GPX4
Molecular Formula C23H22Cl2N2O3S
Purity 0.98
View More Specs

Products 2
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
30000030
View Documents
Tocris Bioscience™
7821/10
10 mg
188.00€
10mg
Veuillez vous pour pouvoir commander cet article. Besoin d'un compte web? Créer le vôtre dès maintenant!
30000010
View Documents
Tocris Bioscience™
7821/50
50 mg
737.00€
50mg
Veuillez vous pour pouvoir commander cet article. Besoin d'un compte web? Créer le vôtre dès maintenant!
Description

Description

ML 162 is a covalent glutathione peroxidase 4 (GPX4) inhibitor. It induces ferroptosis in vivo. It is selectively lethal to mutant RAS oncogene-expressing cell lines (IC50 = 25 and 578 nM for HRASG12V-expressing and wild-type BJ fibroblasts, respectively).
Specifications

Specifications

2-[(Chloroacetyl)(3-chloro-4-methoxyphenyl)amino]-N-(2-phenylethyl)-2-thien-2-ylacetamide
Glutathione Peroxidase 4/GPX4
0.98
1035072-16-2
C23H22Cl2N2O3S
Videos
Safety and Handling

Safety and Handling

Recommended Storage : Store at -20°C

SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.